The biopsy devices market, valued at USD 2.3 billion in 2022, is poised for significant expansion, projected to reach USD 4.2 billion by 2032 at a robust CAGR of 6.1% from 2023 to 2032. This market ...
As of 2022, the ultrasound-guided biopsy market was valued at USD 720 million, showing a consistent upward trend in response to the growing global need for early breast cancer detection. This momentum ...
It offers details on crucial market processes, such as leading participants. Changes in consumer behavioral patterns have temporarily hindered the market’s growth because the size of the Breast Lesion ...
GE HealthCare announces additional clinical applications now available as part of the OEC 3D mobile CBCT C-arm portfolio to help enable precise and efficient imaging during endoscopic bronchoscopy ...